Science-Based Ingredient Firms Spur Bullish Investors In Supplement Sector
This article was originally published in The Tan Sheet
Executive Summary
Buying trends of private equity firms show that ingredient companies are expected to drive growth in the nutritional supplement industry, according to Adams Harkness managing director David Thibodeau
You may also be interested in...
Martek Reaches Beyond Infant Formula To Grab Perinatal, Food Markets
Martek Biosciences is supplying DHA for Mission Pharmacal's upcoming Rx perinatal dietary supplement Citracal + DHA, the firm announced during a presentation to investors
Martek Reaches Beyond Infant Formula To Grab Perinatal, Food Markets
Martek Biosciences is supplying DHA for Mission Pharmacal's upcoming Rx perinatal dietary supplement Citracal + DHA, the firm announced during a presentation to investors
Martek Reaches Beyond Infant Formula To Grab Perinatal, Food Markets
Martek Biosciences is supplying DHA for Mission Pharmacal's upcoming Rx perinatal dietary supplement Citracal + DHA, the firm announced during a presentation to investors